An immunogram is a comprehensive visual representation of an individual's immune system status, integrating multiple parameters including cell populations, functional markers, cytokine profiles, metabolic indicators, and resolution capacity. It provides a personalized immune fingerprint useful for diagnosis, prognosis, and therapeutic monitoring in cPNI practice, moving beyond single biomarkers to capture the multidimensional nature of immune function.
Imagine a city dashboard that monitors every aspect of urban function simultaneously. Instead of just checking traffic flow (one cytokine) or crime rates (one antibody), the dashboard shows traffic density by district (leukocyte subsets), emergency response times (resolution indices), pollution levels (inflammatory markers), power grid efficiency (metabolic state), construction activity (tissue repair markers), and police deployment patterns (immune cell trafficking). When the mayor (clinician) looks at this dashboard, they don't just see "high crime" — they see that crime is concentrated in certain neighborhoods (Th1 skewing), emergency services are overwhelmed (resolution deficit), the power grid is strained (metabolic dysfunction), and construction crews aren't arriving on time (impaired tissue repair). This comprehensive view reveals that the city doesn't need more police (generic anti-inflammatories) — it needs better emergency dispatch protocols (SPMs), more efficient power generation (metabolic optimization), and coordination between departments (immune system rebalancing). The immunogram is this city dashboard for your immune system: a single visual map that shows how all the pieces fit together, revealing patterns that individual measurements would miss.
The immunogram aggregates data across five major domains, each with specific measurement targets:
1. Cellular Domain:
- Leukocyte differential: absolute counts and percentages of neutrophils, lymphocytes, monocytes, eosinophils, basophils
- T cell subsets: CD4+ Th1/Th2/Th17/Treg ratios via flow cytometry
- NK cell populations and activation state (CD56bright vs CD56dim)
- Monocyte phenotypes: CD14++CD16- (classical), CD14++CD16+ (intermediate), CD14+CD16++ (non-classical)
2. Activation Domain:
- Surface markers: HLA antigens-DR expression (monocyte/T cell activation), CD86 (B7-2) costimulation status
- Adhesion molecules: L-selectin (CD62L) for trafficking capacity
- Degranulation markers: CD63/CD107a on NK cells and neutrophils
3. Cytokine Profile Domain:
- Pro-inflammatory: IL-1β, IL-6, TNF-α, IL-12, IFN-γ
- Anti-inflammatory: IL-10, TGF-beta
- Th subset markers: IL-4 (Th2), IL-17 (Th17), IL-22, IL-23
- Chemokines: CCL2 (MCP-1), CXCL1, IL-8
4. Metabolic Domain:
5. Resolution Domain:
graph TD
A[Immunogram Construction] --> B[Cellular Profiling]
A --> C[Activation Status]
A --> D[Cytokine Patterns]
A --> E[Metabolic State]
A --> F[Resolution Capacity]
B --> B1["Flow cytometry: T/B/NK subsets"]
B --> B2[Differential counts]
B --> B3[Monocyte phenotyping]
C --> C1[HLA-DR density]
C --> C2[CD86 costimulation]
C --> C3[CD62L trafficking markers]
D --> D1[Multiplex cytokine array]
D --> D2[Th1/Th2/Th17 ratios]
D --> D3[Chemokine gradients]
E --> E1["GLUT1 expression → Glycolytic"]
E --> E2["CPT1A → FAO capacity"]
E --> E3["ATP/lactate → Metabolic mode"]
F --> F1[SPM quantification]
F --> F2[Resolution indices]
F --> F3[Efferocytosis assays]
B1 --> G[Integrated Visual Display]
B2 --> G
B3 --> G
C1 --> G
C2 --> G
C3 --> G
D1 --> G
D2 --> G
D3 --> G
E1 --> G
E2 --> G
E3 --> G
F1 --> G
F2 --> G
F3 --> G
G --> H[Pattern Recognition]
H --> H1[Th1/Th2 skewing]
H --> H2[Metabolic dysfunction]
H --> H3[Resolution deficit]
H --> H4[Activation excess]
H1 --> I[Targeted Intervention]
H2 --> I
H3 --> I
H4 --> I
Data Integration and Visualization:
Reference ranges are established from healthy cohorts matched for age, sex, and metabolic status. Individual patient values are plotted as radar charts, heatmaps, or color-coded bar graphs showing deviations from normal. Advanced immunograms may include:
- Time-series tracking (serial immunograms showing treatment response)
- Functional assays: oxidative burst capacity (ROS production by neutrophils), phagocytosis efficiency, NK cytotoxicity
- Trained immunity markers: epigenetic modifications (H3K4me3, H3K27ac) or metabolic reprogramming signatures
The immunogram enables precision immunology in cPNI practice, aligning with the five metamodels through personalized assessment:
Metamodel 0 (Evolutionary Mismatch): Reveals patterns consistent with ancestral-modern disconnects. For example, high Th2/low Th1 ratios with metabolic dysfunction suggest hygiene hypothesis consequences and reduced pathogen exposure. Elevated glycolytic markers (GLUT1, lactate) indicate chronic activation incompatible with ancestral intermittent stress patterns.
Metamodel 1 (Selfish Systems): Identifies when immune priorities conflict with host needs. Chronic GLUT1 transporter upregulation shows the Selfish Immune System monopolizing glucose at the expense of brain and muscle. Resolution deficits (low Resolvins, high R_i) indicate the immune system failing to downregulate after threat clearance.
Diagnostic Power:
- Th1/Th2 imbalance: Th1-dominant (IFN-γ/IL-12 high, IL-4/IL-10 low) in autoimmune conditions (Rheumatoid arthritis, Multiple Sclerosis). Th2-dominant (IL-4/IL-5 high) in allergic disease, parasitic infection
- Th17 elevation: IL-17 >50 pg/mL suggests tissue inflammation (psoriasis, IBD, autoimmunity with neutrophilic infiltration)
- Treg dysfunction: CD4+CD25+FOXP3+ <5% of CD4+ cells indicates impaired immune regulation, seen in autoimmunity
- Metabolic dysfunction: GLUT1 expression >70th percentile on resting lymphocytes indicates chronic glycolytic state typical in Metabolic syndrome, Type 2 Diabetes, chronic inflammation
- Resolution deficit: RvD1 <100 pg/mL, MaR1 <50 pg/mL, R_i >12 hours suggests impaired inflammation resolution—common in Chronic pain, Depression, Cardiovascular disease
Clinical Thresholds:
- IL-6 >10 pg/mL: systemic inflammation
- CRP >3 mg/L: cardiovascular risk
- TNF-α >8 pg/mL: chronic inflammatory state
- Neutrophil-lymphocyte ratio >3: stress-induced immune dysregulation
- CD86 expression >40% on monocytes: excessive costimulation (autoimmune risk)
- Lactate/pyruvate ratio >25: metabolic shift toward glycolysis
Intervention Guidance:
- Th1/Th2 rebalancing: Vitamin D (shifts toward Treg), omega-3s (dampens Th1, raises Th2 appropriately), Probiotics (rebalances via SCFA production)
- Metabolic reprogramming: Intermittent fasting, Ketogenic diet, exercise (shift from glycolysis toward FAO, reduce GLUT1, increase mitochondrial efficiency)
- Resolution enhancement: EPA/DHA supplementation (substrate for SPMs), Aspirin (triggers Aspirin-triggered resolvins), Curcumin (enhances ALX-FPR2 signaling)
- Activation dampening: Cold exposure (reduces HLA-DR expression), Vagus nerve stimulation (cholinergic anti-inflammatory pathway), stress reduction (lowers cortisol-driven glycolytic shift)
Monitoring Treatment Response:
Serial immunograms track therapeutic efficacy. Successful intervention shows:
- Normalization of Th ratios
- Reduction in activation markers (HLA-DR, CD86)
- Shift from glycolytic to oxidative metabolism
- Improvement in resolution indices (R_i shortens, SPMs increase)
- Restoration of Treg populations
Complex Chronic Disease Application:
Standard markers (CRP, ESR) fail to capture immune complexity in conditions like Fibromyalgia, Chronic fatigue syndrome, Long COVID, PTSD. Immunograms reveal subtle but critical patterns: preserved cytokine levels but impaired resolution, metabolic exhaustion without overt inflammation, or dysfunctional immune trafficking (abnormal CD62L).
- Integrates 30-50 immune parameters into a single visual profile, compared to 1-3 markers in standard testing
- Standard parameters include: complete leukocyte differential, at least 8 cytokines, 5+ T cell subsets, 3+ activation markers, metabolic indicators, and resolution molecules
- Th1/Th2 balance assessed via IFN-γ/IL-4 ratio: healthy range 3-7, >10 indicates Th1 dominance, <2 indicates Th2 dominance
- Treg populations should constitute 5-10% of CD4+ T cells; <5% indicates regulatory deficit
- Metabolic markers: GLUT1 expression increases 5-10 fold during immune activation; chronically elevated (>3-fold baseline) indicates metabolic dysfunction
- Resolution indices: R_i (resolution interval) should be <8 hours in healthy individuals; >12 hours indicates impaired resolution
- SPM levels: RvD1 typically 100-300 pg/mL, MaR1 50-150 pg/mL, RvE1 80-200 pg/mL in healthy plasma
- Monocyte phenotypes: classical (85%), intermediate (5%), non-classical (10%) in health; intermediate expansion (>10%) indicates chronic inflammation
- Serial immunograms reveal treatment efficacy within 4-8 weeks, faster than clinical symptom improvement
- Cost-effectiveness improves when replacing multiple single-marker tests with comprehensive profiling
- Particularly valuable in conditions where standard inflammatory markers are normal but immune dysfunction persists (chronic pain syndromes, post-viral fatigue, autoimmunity in remission)
- Th1/Th2 balance — central component of immunogram assessment, reveals immune polarization patterns and guides rebalancing interventions
- Resolution indices — quantitative measures of inflammatory resolution capacity included in immunogram, predict chronicity vs recovery
- Specialized pro-resolving mediators (SPMs) — lipid mediators quantified in immunogram resolution domain, therapeutic targets for resolution enhancement
- immunometabolism — metabolic parameters (GLUT1, CPT1A, ATP, lactate) integrated in immunogram reveal energetic state driving immune function
- Cytokines — multiplex cytokine profiling forms core immunogram component, captures inflammatory vs anti-inflammatory balance
- GLUT1 — metabolic marker showing glycolytic immune activation, elevated in chronic inflammatory states
- trained immunity — immunogram may reveal innate immune training via epigenetic markers or metabolic reprogramming signatures
- Metaflammation — chronic low-grade inflammation patterns visible on immunogram (elevated IL-6, TNF-α, reduced resolution markers)
- Immunoresolvents — therapeutic category targeting resolution deficits identified via immunogram (SPM precursors, FPR2 agonists)
- Selfish Immune System — immunogram reveals when immune glucose monopolization (GLUT1 dominance) conflicts with whole-body needs
- HLA antigens-DR — activation marker measured in immunogram, indicates monocyte and T cell stimulation levels
- CD86 — B7-2 costimulatory molecule assessed in immunogram, excessive expression indicates over-activation risk
- Efferocytosis — macrophage clearance of apoptotic cells measured functionally in immunogram resolution domain
- IL-6 — pleiotropic cytokine quantified in immunogram, elevated (>10 pg/mL) indicates systemic inflammation
- IL-10 — anti-inflammatory cytokine in immunogram profile, deficiency indicates impaired regulatory capacity
- Resolvins — D-series and E-series resolvins measured in immunogram, substrate-limited by omega-3 availability
- Maresins — macrophage-derived SPMs included in immunogram, promote tissue regeneration and resolution
- TNF-α — pro-inflammatory cytokine in immunogram, chronic elevation (>8 pg/mL) drives metabolic dysfunction
- Neuroinflammation — immunogram patterns (Th1 dominance, resolution deficit) predict CNS inflammation in depression, neurodegeneration
- Chronic fatigue syndrome — immunogram reveals specific patterns: normal CRP but impaired NK function, resolution deficits, metabolic exhaustion
- Depression — immunogram shows CTRA pattern (conserved transcriptional response to adversity): elevated pro-inflammatory genes, reduced antiviral immunity
- Type 2 Diabetes — immunogram demonstrates metaflammation: chronic IL-6/TNF-α elevation, GLUT1 overexpression, resolution deficit
- Autoimmunity — immunogram identifies specific patterns (Th1/Th17 dominance, Treg deficit, activation marker excess) guiding targeted therapy
- Lipid mediator class switching — shift from pro-inflammatory eicosanoids to pro-resolving SPMs tracked via serial immunograms
- Metabolic flexibility — immunogram metabolic markers reveal capacity to switch between glucose and fat oxidation
- C-reactive protein — acute phase protein included in immunogram but insufficient alone; must integrate with cellular and functional markers